(Q34432813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Piracetam: a review of pharmacological properties and clinical uses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Bengt Winblad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

169-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

Long-term and high-dose piracetam treatment of Alzheimer's disease.

30 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2005.TB00268.X

Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2005.TB00268.X

Piracetam: novelty in a unique mode of action

21 January 2018

1 reference

12 December 2020

Piracetam in the treatment of acute stroke

1 reference

12 December 2020

Beneficial effect of piracetam monotherapy on post-ischaemic palatal myoclonus

1 reference

12 December 2020

Piracetam in acute stroke: a systematic review

1 reference

12 December 2020

Piracetam reverses hippocampal membrane alterations in Alzheimer's disease

1 reference

12 December 2020

Decline across different domains of cognitive function in normal ageing: results of a longitudinal population-based study using CAMCOG.

1 reference

12 December 2020

Patterns of cognitive ageing.

1 reference

12 December 2020

Glutamatergic neurotransmission in aging: a critical perspective.

1 reference

12 December 2020

Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy

1 reference

12 December 2020

Pyrrolidone derivatives

1 reference

12 December 2020

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

1 reference

12 December 2020

What cognitive changes can be expected with normal ageing?

1 reference

12 December 2020

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis

1 reference

12 December 2020

Piracetam inhibits the lipid-destabilising effect of the amyloid peptide Abeta C-terminal fragment.

1 reference

12 December 2020

Piracetam for acute ischaemic stroke.

1 reference

12 December 2020

Influence of the postlesion environment and chronic piracetam treatment on the organization of the somatotopic map in the rat primary somatosensory cortex after focal cortical injury

1 reference

12 December 2020

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

1 reference

12 December 2020

The fate of cognition in very old age: six-year longitudinal findings in the Berlin Aging Study (BASE).

1 reference

12 December 2020

Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam

1 reference

12 December 2020

1 reference

12 December 2020

The effects of piracetam on lipofuscin of the rat cerebellar and hippocampal neurons after long-term alcohol treatment and withdrawal: a quantitative study.

1 reference

12 December 2020

The treatment of severe action myoclonus

1 reference

12 December 2020

Piracetam for the treatment of sickle cell disease in children- a double blind test

1 reference

12 December 2020

Synergistic effects of oxiracetam and piracetam in combination with antiepileptic drugs

1 reference

12 December 2020

Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice.

1 reference

12 December 2020

Beneficial effect of piracetam on renal blood flow in ischemically injured kidneys in the rat.

1 reference

12 December 2020

Piracetam in the treatment of different types of myoclonus

1 reference

12 December 2020

[Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam]

1 reference

12 December 2020

Piracetam and dyslexia: effects on reading tests.

1 reference

12 December 2020

Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

1 reference

12 December 2020

Assessment of the effect of piracetam (Nootrop) on hydrogen clearance in the inner ear

1 reference

12 December 2020

The effect of piracetam on global and regional cerebral blood flow in acute cerebral ischemia of man (author's transl)

1 reference

12 December 2020

Piracetam in the treatment of post-concussional syndrome. A double-blind study

1 reference

12 December 2020

Therapeutic effect of piracetam in a case of posthypoxic action myoclonus (author's transl)

1 reference

12 December 2020

Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsy.

1 reference

12 December 2020

The effects of piracetam in children with dyslexia.

1 reference

12 December 2020

The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy

1 reference

12 December 2020

Piracetam attenuates the changes in the surface potential of the phosphatidylcholine monolayer produced by alcohols.

1 reference

12 December 2020

Effect of piracetam on cerebral blood flow and somatosensory evoked potential during normotension and hypotensive ischemia in cats.

1 reference

12 December 2020

Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology

1 reference

12 December 2020

Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures

1 reference

12 December 2020

[Genesis of a drug: Piracetam. Metabolism and biochemical research]

1 reference

12 December 2020

Effects of membrane fluidity on secretion and receptor stimulation

1 reference

12 December 2020

Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro

1 reference

12 December 2020

Piracetam activity may differ according to the age of the recipient mouse.

1 reference

12 December 2020

Piracetam in sickle-cell anaemia

1 reference

12 December 2020

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

1 reference

12 December 2020

Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment

1 reference

12 December 2020

Facilitation of diazepam action by anticonvulsant agents against picrotoxin induced convulsions.

1 reference

12 December 2020

Potentiation of the anticonvulsant effects of antiepileptic drugs by "nootropics"; a potential new therapeutic approach.

1 reference

12 December 2020

Diminished adherence of sickle erythrocytes to cultured vascular endothelium by piracetam

1 reference

12 December 2020

The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin

1 reference

12 December 2020

Piracetam and acetamide in sickle-cell disease

1 reference

12 December 2020

Piracetam diminishes hippocampal acetylcholine levels in rats

1 reference

12 December 2020

Erythrocyte Deformability in Sickle‐Cell Crisis

1 reference

12 December 2020

The activating action of vincamine, piracetam, and hydergine on the activity of the noradrenergic neurons of the locus coeruleus

1 reference

12 December 2020

Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity

1 reference

12 December 2020

Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis

1 reference

12 December 2020

Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake

1 reference

12 December 2020

N-methyl-D-aspartate receptor density and membrane fluidity as possible determinants of the decline of passive avoidance performance in aging.

1 reference

12 December 2020

Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment.

1 reference

12 December 2020

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

12 December 2020

Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain.

1 reference

12 December 2020

Effectiveness of piracetam in cortical myoclonus.

1 reference

12 December 2020

Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects

1 reference

12 December 2020

Availability and plasma clearance of piracetam in man.

1 reference

12 December 2020

Piracetam promotes mossy fiber synaptic reorganization in rats withdrawn from alcohol

1 reference

12 December 2020

Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.

1 reference

12 December 2020

Clinical global impressions in Alzheimer's clinical trials.

1 reference

12 December 2020

Piracetam in the treatment of myoclonus: an overview.

1 reference

12 December 2020

Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain.

1 reference

12 December 2020

Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo

1 reference

12 December 2020

10.1111/J.1527-3458.2005.TB00268.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16007238%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference